Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate

Journal of Infectious Diseases

Volumn 195, Issue 4, 2007, Pages 562-571

  Traina Dorge, Vicki L ^a   Martin, Louis N ^a   Lorino, Rebecca ^a   Winsor, Elsa L ^b   Beilke, Mark A ^b,c  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN P19;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN T CELL LEUKEMIA VIRUS 1; INOCULATION; MACACA; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PRIMATE; PRIORITY JOURNAL; PROVIRUS; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; ANTIGENS, CD2; ANTIGENS, CD4; ANTIGENS, CD8; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, GAG; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MACACA MULATTA; MALE; MICROSCOPY; PROVIRUSES; RETROVIRIDAE PROTEINS, ONCOGENIC; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 33846785629     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510914     Document Type: Article

References (50)

1. Hinuma Y, Nagata K, Hanoaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78:6476-80.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JK, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77:7415-9.
3. Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 2002; (Suppl 2):240-5.
4. Gessain A, Caudie C, Gout O, et al. Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infect Dis 1988; 157:1226-34.
5. Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 2002; 186(Suppl 2):S187-92.
6. Witkor SZ, Cannon RO, Atkinson WL, et al. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis 1992; 165:920-4.
7. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326:375-80.
8. Harrison LH, Vaz B, Taveira DM, et al. Myelopathy among Brazilians co-infected with HTLV-I and HIV. Neurology 1997; 48:13-8.
9. Beilke MA, Japa S, Vinson DG. HTLV-I and HTLV-II virus expression increase with HIV-1 co-infection. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:391-7.
10. Beilke MA, Theall KP, O'Brien M, et al. Clinical outcomes and disease progression among patients coinfect with HIV and human T lymphotropic viruses types 1 and 2. Clin Infect Dis 2004; 39:256-63.
11. Murphy EL, Grant RM, Kropp J, Oliveira A, Lee TH, Bush MP. Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients. J Acquir Immune Defic Syndr 2003; 33:655-6.
12. Beilke MA, Japa S, Moeller-Hadi C, Martin-Schild S. Tropical spastic paraparesis/HTLV-1-associated myelopathy in HIV-1 coinfected patients. Clin Infect Dis 2005; 41:e57-63.
13. Hayami M. Simian T-cell leukemia virus - HTLV-1 related virus in non-human primates. In: Takatsuki K, Hinum Y, Yoshida M, eds. Gann monograph on cancer research. Vol 39. Tokyo: Japan Scientific Societies Press, 1992:247-56.
14. Saksena NK, Herve V, Durand JP, et al. Seroepidemiologic, molecular, and phylogenetic analyses of simian T-cell leukemia viruses (STLV-1) from various naturally infected monkey species from central and western Africa. Virology 1994; 198:297-310.
15. Slattery JP, Franchini G, Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 1999; 9:525-40.
16. Koralnik IJ, Boeri E, Saxinger WC, et al. Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type 1 strains: evidence for interspecies transmission. J Virol 1994; 68:2693-707.
17. Liu HF, Goubou P, Van Brussel M, et al. The three distinct human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirs. J Gen Virol 1996; 77:359-68.
18. Mahieux R, Ibrahim F, Mauclere P, et al. Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa in Pygmies. J Virol 1997; 71:1317-33.
19. Van Dooren S, Salemi M, Vandamme AM. Dating the origin of the African human T-cell lymphotropic virus type 1 subtypes. Mol Biol Evol 2001; 18:661-71.
20. Meertens L, Rigoulet J, Mauclere P, et al. Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology 2001; 287:275-85.
21. Tsujimoto H, Noda Y, Ishikawa K, et al. Development of adult T-cell leukemia-like disease in African green monkey naturally associated with clonal integration of simian T-cell leukemia virus type I. Cancer Res 1987; 47:269-74.
22. Traina-Dorge V, Blanchard J, Martin L, Murphey-Corb M. Immunodeficiency and lymphoproliferative disease in an African green monkey dually infected with SIV and STLV-I. AIDS Res Hum Retroviruses 1992; 8:97-100.
23. Hubbard GB, Mone JP, Allan JS, et al. Spontaneously generated non-Hodgkin's lymphoma in twenty-seven simian T-cell leukemia virus type 1 antibody-positive baboons (Papio species). Lab Anim Sci 1993; 43:301-9.
24. Allen JS, Leland M, Broussard S, Mone J, Hubbard G. Simian T-cell lymphotropic viruses and lymphomas in African nonhuman primates. Cancer Invest 2001; 19:383-95.
25. Yamamoto N., Hayami M, Komuro A,et al. Experimental infection of cynomolgus monkeys with a human retrovirus, adult T-cell leukemia virus. Med Microbiol Immunol 1984; 173:57-64.
26. Nakamura H, Tanaka Y, Komuro-Tsujimoto A, et al. Experimental inoculation of monkeys with autologous lymphoid cell lines immortalized by and producing human T-cell leukemia virus type-I. Int J Cancer 1986; 38:867-75.
27. Beilke MA, Traina-Dorge VL, England JD, Blanchard J. Polymyositis, arthritis and uveitis in a macaque experimentally infected with HTLV-1. Arthritis Rheum 1996; 39:610-5.
28. Kazanji M, Moreau JP, Mahieux R, et al. HTLV-I infection in squirrel monkeys (Saimiri sciureus) using autologous, homologous or heterologous HTLV-I transformed cell lines. Virology 1997; 231:258-66.
29. Kazanji M, Tartaglia J, Franchini G, et al. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus). J Virol 2001; 75:5939-48.
30. Mortreaux F, Kazanji M, Gabet AS, de Thoisy B, Wattel E. Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J Virol 2001; 75: 1083-9.
31. Heraud JM, Mortreaux F, Merien F, et al. The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus). Antiviral Res 2006; 70:132-9.
32. Kazanji M, Heraud JM, Merien F, et al. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus). J Gen Virol 2006; 87:1331-7.
33. Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet Pathol 1988; 25:456-67.
34. Martin LN, Murphey-Corb M, Soike KF, Davison-Fairburn B, Baskin GB. Effects of initiation of 3′-azido, 3′-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Infect Dis 1993; 168:825-35.
35. Ling B, Veazey RS, Penedo C, Xu K, Lifson JD, Marx PA. Longitudinal follow up of SIVmac pathogenesis in rhesus macaques of Chinese origin: emergence of B cell lymphoma. J Med Primatol 2002; 31:154-63.
36. Beilke MA, Greenspan DL, Impey A, Thompson J, Didier PJ. Laboratory study of HIV-1 and HTLV-I/II co-infection. J Med Virol 1994;44:132-43.
37. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 1983; 80:3618-22.
38. Clarke MF, Gelmann EP, Reitz MS Jr. Homology of HTLV envelope gene with class I HLA gene. Nature 1983; 305:60-2.
39. Catovsky D, Foa R. The lymphoid leukemias. London: Butterworths, 1990:73-112.
40. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 1986; 5:2883-8.
41. Franchini G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type 1 Infection. Blood 1995; 86:3619-39.
42. Yamaguchi K, Kiyokawa T, Futami G, Ishii T, Takatsuki K. Pathogenesis of adult T-cell leukemia from clinical pathologic features. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Reven Press; 1990:163-71.
43. Sacher RA, Luban NL, Ameti DI, Friend S, Schreiber GB, Murphy EL. Low prevalence of flower cells in USA blood donors infected with human T-lymphoctrophic virus types I and II. Br J Haematol 1999; 105:758-63.
44. Shibata D, Byrnes RK, Rabinowitz A, et al. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Int Med 1989; 111:871-5.
45. Nadler JP, Bach MC, Godofsky E. Management of co-infection with human immunodeficiency virus and human T-cell lymphotropic virus type I. Clin Infect Dis 1996; 23:415.
46. Sakai JA, Nagai M, Brennan MB, Mora CA, Jacobson S. In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type 1- associated neurologic disease: predominant expansion of CD8+ T cells. Blood 2001; 98:1506-11.
47. Yamano Y, Cohen CJ, Takenouchi N, et al. Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human-histocompatibility leukocyte antigen A*201 complexes on CD4+CD25+ T cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med 2004; 199:1367-77.
48. Nagai M, Brennan M, Sakai JA, Mora CA, Jacobson S. CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 2001; 98:1858-61.
49. Eggena MP, Barugahare B, Jones N, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005; 174:4407-14.
50. Fultz PN, McGinn T, Davis lC, Romano JW, Li Y. Co-infection of macaques with SIV and STLV type I: effects on virus burdens and disease progression. J Infect Dis 1999; 179:600-11.